Transcatheter aortic valve implantation with different self-expanding devices - a propensity score matched multicenter comparison.

[1]  R. Kornowski,et al.  Comparison of transcatheter aortic valve replacement with the ACURATE neo2 versus Evolut PRO/PRO+ devices. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[2]  D. Wood,et al.  Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2. , 2022, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[3]  Won-Keun Kim,et al.  Neo to Neo2: A Tiny Detail With Considerable Impact. , 2022, JACC: Cardiovascular Interventions.

[4]  C. Cuccia,et al.  Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes. , 2022, JACC. Cardiovascular interventions.

[5]  K. Toutouzas,et al.  TAVI with ACURATE neo transcatheter heart valve in special populations: A systematic review. , 2022, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[6]  K. Toutouzas,et al.  Study Level Meta-Analysis of Transcatheter Aortic Valve Implantation With the ACURATE neo Self-Expanding Transcatheter Heart Valve , 2022, Cardiology in review.

[7]  J. Hausleiter,et al.  TAVI in patients with low-flow low-gradient aortic stenosis–short-term and long-term outcomes , 2022, Clinical Research in Cardiology.

[8]  S. Windecker,et al.  Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  A. Rück,et al.  Outcomes Following Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: SWEDEHEART Observational Study. , 2021, JACC. Cardiovascular interventions.

[10]  M. Leon,et al.  Paravalvular Regurgitation Post-Transcatheter Aortic Valve Replacement in Intermediate Risk Patients: A Pooled PARTNER 2 Study. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  B. Prendergast,et al.  2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.

[12]  F. Alfonso,et al.  Transcatheter aortic valve replacement using the new Evolut-Pro system: a prospective comparison with the Evolut-R device , 2021, Journal of thoracic disease.

[13]  M. Joner,et al.  The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes , 2021, Clinical Research in Cardiology.

[14]  Jeroen J. Bax,et al.  Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. , 2021, Journal of the American College of Cardiology.

[15]  M. Mack,et al.  2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Circulation.

[16]  C. Hengstenberg,et al.  Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis , 2020, Circulation.

[17]  M. Körber,et al.  Impact of device landing zone calcification patterns on paravalvular regurgitation after transcatheter aortic valve replacement with different next-generation devices , 2020, Open Heart.

[18]  F. Neumann,et al.  5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial. , 2020, JACC. Cardiovascular interventions.

[19]  M. Dalby,et al.  Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry. , 2020, International journal of cardiology.

[20]  T. Nazif,et al.  Three Generations of Self-Expanding Transcatheter Aortic Valves: A Report From the STS/ACC TVT Registry. , 2020, JACC. Cardiovascular interventions.

[21]  S. Buccheri,et al.  Outcomes of three different new generation transcatheter aortic valve prostheses , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  L. Fauchier,et al.  Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis , 2019, Circulation.

[23]  B. Prendergast,et al.  Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial , 2019, The Lancet.

[24]  C. Grines,et al.  Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement , 2019, Journal of interventional cardiology.

[25]  T. Walther,et al.  Impact of new pacemaker implantation following surgical and transcatheter aortic valve replacement on 1-year outcome. , 2019, European Journal of Cardio-Thoracic Surgery.

[26]  Andrew S. Mugglin,et al.  Transcatheter Aortic‐Valve Replacement with a Self‐Expanding Valve in Low‐Risk Patients , 2019, The New England journal of medicine.

[27]  W. Rottbauer,et al.  Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves. , 2019, JACC. Cardiovascular interventions.

[28]  C. Meduri,et al.  Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial , 2019, JAMA cardiology.

[29]  C. Jung,et al.  The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement: Matched Comparison of the Evolut PRO and Evolut R. , 2018, JACC. Cardiovascular interventions.

[30]  P. Serruys,et al.  One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[31]  Jeroen J. Bax,et al.  Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review , 2018, European heart journal.

[32]  T. Kuntze,et al.  Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[33]  J. Oh,et al.  Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. , 2018, JACC. Cardiovascular interventions.

[34]  C. Hengstenberg,et al.  Short-Term Outcome and Hemodynamic Performance of Next-Generation Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients With Small Aortic Annulus: A Multicenter Propensity-Matched Comparison , 2017, Circulation. Cardiovascular interventions.

[35]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[36]  T. Walther,et al.  Transfemoral aortic valve implantation using a self-expanding transcatheter heart valve without pre-dilation. , 2017, International journal of cardiology.

[37]  S. Windecker,et al.  Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study. , 2017, Journal of the American College of Cardiology.

[38]  G. Hasenfuss,et al.  Long-term outcomes after TAVI in patients with different types of aortic stenosis: the conundrum of low flow, low gradient and low ejection fraction. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[39]  I. Meredith,et al.  Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System. , 2015, JACC. Cardiovascular interventions.

[40]  Philippe Pibarot,et al.  Assessment of paravalvular regurgitation following TAVR: a proposal of unifying grading scheme. , 2015, JACC. Cardiovascular imaging.

[41]  J. Mehilli,et al.  Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. , 2014, JAMA.

[42]  J. Kempfert,et al.  Symetis ACURATE TF™ aortic bioprosthesis. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[43]  Alexander Ghanem,et al.  Evaluation and management of paravalvular aortic regurgitation after transcatheter aortic valve replacement. , 2013, Journal of the American College of Cardiology.